MASIMO CORP
Clinical trial NCT06922461 updates: 1. status: WITHHELD → TERMINATED 2. start date: not set → 2025-05-02 3. completion date: not set → 2025-05-22 4. primary completion date: not set → 2025-05-22 5. enrollment: not set → 4 participants 6. study type: not set → INTERVENTIONAL 7. enrollment type: not set → ACTUAL 8. allocation: not set → NA 9. intervention model: not set → SINGLE_GROUP 10. primary purpose: not set → OTHER 11. masking: not set → NONE
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical